Jamie T Choi, NP
Nurse Practitioner · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 7
Offices
7 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Jamie T Choi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$50,439
Medicare paid this office $50,439 for 244 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 219 | $41,348 | $104 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 204 | $3,339 | $13 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $3,293 | $75 |
Who their Medicare patients are
244 Original Medicare patients in 2024. Average age 72 · Under 65 22% · 85 and older 13% · Women 64% · Also on Medicaid 25% · Health risk score 1.41. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 66% · Depression 38% · Coronary heart disease 28% · Diabetes 27% · Chronic kidney disease 27% · Heart failure 19% · COPD 17% · Atrial fibrillation 13% · Cancer 12% · Dementia 5% · Stroke 5%.
The office billed $180,355, Medicare allowed $63,734 and paid $50,439; for 723 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 244 | 723 | 72 | 1.41 | $180,355 | $50,439 |
| 2023 | 133 | 939 | 85 | 1.85 | $120,831 | $34,127 |
| 2022 | 187 | 1,693 | 85 | 1.60 | $131,305 | $41,823 |
| 2021 | 95 | 387 | 84 | 1.62 | $24,262 | $8,761 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Short return visit (20+ min) | 78 | $17,819 | $66 |
| Return visit (30+ min) | 56 | $9,129 | $88 |
| Insertion of needle into vein for collection of blood sample | 109 | $2,663 | $8 |
| Removal of impacted ear wax | 29 | $1,428 | $34 |
| Injection of drug or substance under skin or into muscle | 11 | $1,007 | $9 |
| Short return visit | 11 | $742 | $29 |
2022: 8 services
| Short return visit | 80 | $17,207 | $43 |
| Short return visit (20+ min) | 49 | $7,233 | $69 |
| Adm sarscv2 bvl 30mcg/.3ml a | 118 | $4,878 | $41 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, tris-sucrose formulation; booster dose | 93 | $3,823 | $41 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 34 | $2,886 | $17 |
| Insertion of needle into vein for collection of blood sample | 117 | $1,593 | $3 |
| Injection of drug or substance under skin or into muscle | 13 | $1,515 | $11 |
| Removal of impacted ear wax | 15 | $904 | $36 |
2021: 4 services
| Short return visit | 45 | $4,387 | $46 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $1,894 | $20 |
| Short return visit (20+ min) | 20 | $1,770 | $74 |
| Insertion of needle into vein for collection of blood sample | 80 | $390 | $3 |
Drugs they prescribed that Part D paid
$303,866
Pharmacies billed $303,866 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 67% of their Part D prescriptions (2,282 of 3,430) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 28% of their opioid prescriptions.
3,127 generic and 303 brand-name prescriptions · $303,866 in drug cost · 12 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine | 326 | $92,098 | $283 |
| Belbuca | 69 | $56,020 | $812 |
| Oxycontin | 39 | $25,219 | $647 |
| Hydrocodone-Acetaminophen | 727 | $22,516 | $31 |
| Butrans | 27 | $14,252 | $528 |
See all 32 drugs
| Buprenorphine | 326 | $92,098 | $283 |
| Belbuca | 69 | $56,020 | $812 |
| Oxycontin | 39 | $25,219 | $647 |
| Hydrocodone-Acetaminophen | 727 | $22,516 | $31 |
| Butrans | 27 | $14,252 | $528 |
| Oxycodone-Acetaminophen | 286 | $12,583 | $44 |
| Naloxone | 140 | $8,601 | $61 |
| Buprenorphine | 212 | $7,278 | $34 |
| Oxycodone | 327 | $6,196 | $19 |
| Buprenorphine-Naloxone | 25 | $5,417 | $217 |
| Pregabalin | 157 | $5,285 | $34 |
| Fentanyl | 19 | $3,985 | $210 |
| Gabapentin | 151 | $3,586 | $24 |
| Hydromorphone | 140 | $2,601 | $19 |
| Lidocaine | 26 | $2,517 | $97 |
| Morphine Sulfate Er | 83 | $2,414 | $29 |
| Morphine Sulfate | 50 | $2,231 | $45 |
| Tramadol | 86 | $959 | $11 |
| Tramadol Hcl Er | 23 | $881 | $38 |
| Methadone | 41 | $686 | $17 |
| Tizanidine | 61 | $633 | $10 |
| Cyclobenzaprine | 60 | $627 | $10 |
| Celecoxib | 28 | $604 | $22 |
| Diclofenac | 19 | $565 | $30 |
| Acetaminophen-Codeine | 24 | $489 | $20 |
| Baclofen | 37 | $437 | $12 |
| Methocarbamol | 19 | $226 | $12 |
| Quetiapine | 14 | $193 | $14 |
| Duloxetine | 14 | $150 | $11 |
| Zolpidem | 19 | $118 | $6 |
| Hydroxyzine | 16 | $80 | $5 |
| Meloxicam | 13 | $14 | $1 |
Year by year
| 2024 | 3,430 | 792 | 67% (2,282) | 9% | $303,866 |
| 2023 | 208 | 60 | 0% (0) | 13% | $6,702 |
| 2022 | 259 | 95 | None | 8% | $8,920 |
| 2021 | 2,369 | 250 | 47% (1,107) | 7% | $132,739 |
| 2020 | 956 | 199 | 53% (505) | 9% | $49,706 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Gabapentin | 31 | $434 | $14 |
| Fluticasone Propionate | 12 | $335 | $28 |
| Potassium Chloride | 13 | $143 | $11 |
2022: 6 drugs
| Lokelma | 18 | $1,491 | $83 |
| Nitrofurantoin Mono-Macro | 19 | $609 | $32 |
| Cyclobenzaprine | 18 | $287 | $16 |
| Gabapentin | 27 | $283 | $10 |
| Triamcinolone Acetonide | 11 | $109 | $10 |
| Ibuprofen | 12 | $85 | $7 |
2021: 26 drugs
| Hydrocodone-Acetaminophen | 565 | $15,539 | $28 |
| Xtampza Er | 16 | $10,520 | $657 |
| Oxycontin | 21 | $9,513 | $453 |
| Suboxone | 14 | $8,745 | $625 |
| Pregabalin | 126 | $6,679 | $53 |
| Oxycodone-Acetaminophen | 155 | $6,227 | $40 |
| Movantik | 15 | $5,988 | $399 |
| Narcan | 32 | $4,342 | $136 |
| Oxycodone | 157 | $4,225 | $27 |
| Gabapentin | 243 | $3,957 | $16 |
| Fentanyl | 37 | $3,565 | $96 |
| Diclofenac | 116 | $2,557 | $22 |
| Lidocaine | 27 | $2,514 | $93 |
| Cyclobenzaprine | 160 | $2,453 | $15 |
| Morphine Sulfate Er | 49 | $1,423 | $29 |
| Duloxetine | 38 | $1,298 | $34 |
| Baclofen | 54 | $1,188 | $22 |
| Celecoxib | 41 | $1,121 | $27 |
| Tizanidine | 96 | $1,075 | $11 |
| Ibuprofen | 91 | $828 | $9 |
| Zolpidem | 57 | $600 | $11 |
| Trazodone | 35 | $383 | $11 |
| Tramadol | 56 | $327 | $6 |
| Ondansetron Odt | 11 | $323 | $29 |
| Methadone | 16 | $205 | $13 |
| Morphine Sulfate | 13 | $162 | $12 |
2020: 19 drugs
| Hydrocodone-Acetaminophen | 244 | $6,801 | $28 |
| Oxycontin | 14 | $6,232 | $445 |
| Narcan | 36 | $4,624 | $128 |
| Oxycodone-Acetaminophen | 62 | $2,414 | $39 |
| Oxycodone | 81 | $2,159 | $27 |
| Fentanyl | 15 | $1,819 | $121 |
| Diclofenac | 48 | $1,788 | $37 |
| Pregabalin | 31 | $1,589 | $51 |
| Lidocaine | 16 | $1,493 | $93 |
| Gabapentin | 83 | $1,357 | $16 |
| Morphine Sulfate Er | 29 | $956 | $33 |
| Cyclobenzaprine | 60 | $772 | $13 |
| Tizanidine | 45 | $592 | $13 |
| Baclofen | 15 | $265 | $18 |
| Ibuprofen | 31 | $214 | $7 |
| Zolpidem | 19 | $207 | $11 |
| Tramadol | 23 | $184 | $8 |
| Trazodone | 15 | $103 | $7 |
| Hydromorphone | 11 | $77 | $7 |
Money from drug and device companies
$192 in 2021
A payment is not proof that care is biased.
| Biohaven Pharmaceuticals | Nurtec Odt | $50 | 2 payments
|
| Teva Pharmaceuticals USA | Ajovy | $30 | 1 payment
|
| Bioventus | Gelsyn-3 | $21 | 1 payment
|
| Nalu Medical | Nalu Neurostimulation System | $20 | 1 payment
|
| GRT US Holding | Qutenza | $20 | 1 payment
|
| Nevro | Omnia | $17 | 1 payment
|
See all 9 published payments
| Collegium Pharmaceutical | Meals · 2021-09-09 | Xtampza | $17 |
| Bioventus | Meals · 2021-08-04 | Gelsyn-3 | $21 |
| Teva Pharmaceuticals USA | Meals · 2021-07-28 | Ajovy | $30 |
| Nevro | Meals · 2021-07-14 | Omnia | $17 |
| Nalu Medical | Meals · 2021-06-30 | Nalu Neurostimulation System | $20 |
| GRT US Holding | Meals · 2021-06-12 | Qutenza | $20 |
| Biohaven Pharmaceuticals | Meals · 2021-04-07 | Nurtec Odt | $28 |
| Abbott Laboratories | Meals · 2021-03-23 | Proclaim Ipg | $17 |
| Biohaven Pharmaceuticals | Meals · 2021-03-23 | Nurtec Odt | $22 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1952843286
- Licence
- CA 95006340
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2016-11-17
- NPI last updated
- 2024-03-06
- NPI record certified
- 2024-03-06
This is when the NPI record was last certified, not a medical board exam.